https://www.marketscreener.com/quote/stock/NEUBASE-THERAPEUTICS-INC-61956606/news/NeuBase-Therapeutics-Presents-New-Preclinical-Data-at-MDA-2022-for-its-Myotonic-Dystrophy-Type-1-Pro-39753478/?utm_source=telegram&utm_medium=social&utm_campaign=share